Patents Assigned to HC PHARMACEUTICAL CO., LTD.
  • Publication number: 20230227444
    Abstract: The present invention relates to a compound as shown in general formula (I) below (in formula (I), each of R1 and R2 independently represents a hydrogen atom or a C1-10 linear or branched alkyl optionally having a substituent, or the two together form a cycloalkyl with 3 to 8 ring carbon atoms; each of R3 and R4 independently represents a hydrogen atom or a C1-10 linear or branched alkyl optionally having a substituent or a C6-12 aryl optionally having a substituent, or the two together form a cycloalky with 3 to 8 ring carbon atoms; X represents C or N; and Y represents a linear or branched alkenyl or alkynyl with 2 to 6 carbon atoms and optionally having a substituent, or carboxyl). The compound has good antibacterial properties against bacteria, especially gram-negative bacteria, has low drug resistance, and has good prospects for the effective treatment of various conditions.
    Type: Application
    Filed: April 30, 2021
    Publication date: July 20, 2023
    Applicants: INSTITUTE OF MEDICINAL BIOTECHNOLOGY, CHINESE ACADEMY OF MEDICAL SCIENCES, GUANGZHOU HC PHARMACEUTICAL CO. LTD
    Inventors: Danqing SONG, Sheng TANG, Xuefu YOU, Zhiwen LI, Yanxiang WANG, Xi LU, Yinghong LI, Xinxin HU, Zhihao GUO, Xiukun WANG
  • Publication number: 20140371284
    Abstract: Provided are imidazolidinedione compounds of formula (I), processes for preparation, uses and pharmaceutically compositions thereof. Said imidazolidinedione compounds posses androgen receptor antagonist activity and can be used for preventing and treating diseases and disorders related to androgen receptor, such as prostate cancer, alopecia, hair regeneration, acne and adolescent acne.
    Type: Application
    Filed: December 13, 2012
    Publication date: December 18, 2014
    Applicant: HC PHARMACEUTICAL CO., LTD.
    Inventor: Yuanwei Chen